RT Book, Section
A1 Meyer, Jonathan M.
A2 Brunton, Laurence L.
A2 Hilal-Dandan, Randa
A2 Knollmann, Björn C.
SR Print(0)
ID 1162535494
T1 Pharmacotherapy of Psychosis and Mania
T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259584732
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1162535494
RD 2024/04/18
AB AbbreviationsACEI:  angiotensin-converting  enzyme  inhibitorAUC:  area  under  the  curveCBC:  complete  blood  cell  countCNS:  central  nervous  systemCOX-2:  cyclooxygenase  2CV:  cardiovascularDA:  dopamineDAAO:D-amino  acid  oxidaseDAT:  DA  transporterDM:  diabetes  mellitusECG:  electrocardiogramECT:  electroconvulsive  therapyeGFR:  estimated  glomerular  filtration  rateEM:  extensive  metabolizerENaC:  epithelial  sodium  channelEPS:  extrapyramidal  symptomFDA:  Food  and  Drug  AdministrationG-CSF:  granulocyte  colony-stimulating  factorGFR:  glomerular  filtration  rateGlyT:  glycine  transporterGSK:  glycogen  synthase  kinase5HT:  serotoninIkr:  inwardly  rectifying  K+  channelsIM:  intramuscularLAI:  long-acting  injectableMAO:  monoamine  oxidasemGlu:  metabotropic  glutamateNDI:  nephrogenic  diabetes  insipidusNE:  norepinephrineNMDA:N-methyl-D-aspartateNMS:  neuroleptic  malignant  syndromeODT:  oral  dissolving  tabletPDP:  Parkinson  disease  psychosisPET:  positron  emission  tomographyPGP:  P-glycoproteinPK_:  protein  kinase  _,  as  in  PKA,  PKCPP2A:  protein  phosphatase  2ASCD:  sudden  cardiac  deathT4:  levorotatory  thyroxineTD:  tardive  dyskinesiaTH:  tyrosine  hydroxylaseTSH:  thyrotropin  (previously  thyroid-stimulating  hormone)VMAT2:  vesicular  monoamine  transporter  2